Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events

BACKGROUND: The benefit of aspirin among patients with stable atherosclerosis without a prior ischemic event is not well defined. HYPOTHESIS: Aspirin would be of benefit in outpatients with atherosclerosis with prior ischemic events, but not in those without ischemic events. METHODS: Subjects from t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Bavry, Anthony A., Elgendy, Islam Y., Elbez, Yedid, Mahmoud, Ahmed N., Sorbets, Emmanuel, Steg, Philippe Gabriel, Bhatt, Deepak L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2017
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490549/
https://ncbi.nlm.nih.gov/pubmed/28520215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22724
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares